rheumatoid arthritis
Conditions
Interventions
WM group early stage :NA
TCM group early stage :NA
Subacute Stage RA WM Group:NA
Subacute Stage RA TCM Group:NA
Chronic Stage RA WM Group:NA
Chronic Stage RA TCM Group:NA
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ?Patients who meet the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis (RA). ?Patients in the early stage, subacute stage, or chronic stage of RA (Rheumatoid Arthritis), specifically: Early-stage or subacute-stage RA patients. Chronic-stage RA patients (Late-stage Rheumatoid Arthritis). ?DAS28 (Disease Activity Score in 28 joints) > 2.6. ?Patients with RA who meet one of the following TCM syndrome patterns: Spleen deficiency with wind-cold-dampness obstruction syndrome. Spleen deficiency with damp-heat-stasis obstruction syndrome. Spleen-kidney deficiency with phlegm-stasis obstruction syndrome. ?Age between 18 and 65 years old. ?Patients who are informed about the study and provide their voluntary consent to participate.
Exclusion criteria
Exclusion criteria: ?Patients with severe organ damage or those suffering from severe mental disorders. ?Patients who have allergies to the drugs involved in the research protocol or have contraindications for their use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ACR20/50/70 Improvement Rate;DAS28 Remission Rate;DAS28 Low Activity Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| CDAI Remission Rate;SDAI Remission Rate;Incidence Rate of Adverse Events;SF-36 Health Survey;Health Assessment Questionnaire Disability Index" (HAQ-DI);Functional Assessment of Chronic Illness Therapy - Fatigue;Traditional Chinese Medicine Syndrome Score; | — |
Countries
China
Contacts
Public ContactChengping Wen
Zhejiang Chinese Medical University
Outcome results
None listed